
Monday, May 29, 2023 12:45:56 PM
The comp was to to SOC arms of other trials and clearly has the concerns the FDA expresses
Its EITHER a trial OR SOC cant be both
Ms. Powers, CEO of NW Bio, commented: “We are excited to see the meaningful survival extensions in glioblastoma patients treated with DCVax®-L in this trial – particularly in the “long tail” of the survival curve, where we see more than double the survival rates as with existing standard of care. With well over 400 clinical trials for glioblastoma having failed over the last 15 years, it is gratifying to be able to offer new hope to patients who face this devastating disease.”
Treatment that is accepted by medical experts as a proper treatment for a certain type of disease and that is widely used by healthcare professionals. Also called best practice, standard medical care, and standard therapy
SOC data is NOT pre selected trial data
Recent NWBO News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
- Nightfood, Inc. (OTCQB: NGTF) now in Sonesta International Hotels Multiple Brands • InvestorsHub NewsWire • 03/13/2023 11:35:55 AM
- Northwest Bio Accuses Market Makers of Share Price Manipulation • TipRanks • 12/01/2022 03:29:04 PM
FEATURED Volcon Announces First Shipment of Newly Updated Grunt EVO Electric Motorcycle Units • Sep 29, 2023 10:16 AM
Integrated Ventures Reports $3,862,849 In Yearly Mining Revenues With 162 Bitcoins Produced • INTV • Sep 29, 2023 10:00 AM
Branded Legacy Inc. Unveils Exciting Q4 2023 Milestones and Forges Ahead with Key Partnerships • BLEG • Sep 28, 2023 10:44 AM
UC Asset Signed MOU with Tenant to Build 8000 sq ft Cannabis Property • UCASU • Sep 28, 2023 9:00 AM
Goldshore Summer Field Program Identifies Five New Gold Trends Including Two High Grade Copper-Gold Trends • GSHRF • Sep 28, 2023 8:03 AM
SciSparc Announces Expected Implementation of 1-for-26 Reverse Share Split • SPRC • Sep 27, 2023 9:49 AM